1. Home
  2. TEVA vs IOT Comparison

TEVA vs IOT Comparison

Compare TEVA & IOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • IOT
  • Stock Information
  • Founded
  • TEVA 1901
  • IOT 2015
  • Country
  • TEVA Israel
  • IOT United States
  • Employees
  • TEVA N/A
  • IOT N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • IOT Retail: Computer Software & Peripheral Equipment
  • Sector
  • TEVA Health Care
  • IOT Technology
  • Exchange
  • TEVA Nasdaq
  • IOT Nasdaq
  • Market Cap
  • TEVA 23.7B
  • IOT 26.3B
  • IPO Year
  • TEVA N/A
  • IOT 2021
  • Fundamental
  • Price
  • TEVA $16.75
  • IOT $52.83
  • Analyst Decision
  • TEVA Strong Buy
  • IOT Buy
  • Analyst Count
  • TEVA 6
  • IOT 14
  • Target Price
  • TEVA $24.17
  • IOT $50.86
  • AVG Volume (30 Days)
  • TEVA 15.5M
  • IOT 3.2M
  • Earning Date
  • TEVA 01-29-2025
  • IOT 03-06-2025
  • Dividend Yield
  • TEVA N/A
  • IOT N/A
  • EPS Growth
  • TEVA N/A
  • IOT N/A
  • EPS
  • TEVA N/A
  • IOT N/A
  • Revenue
  • TEVA $16,544,000,000.00
  • IOT $1,179,183,000.00
  • Revenue This Year
  • TEVA $5.31
  • IOT $33.56
  • Revenue Next Year
  • TEVA $1.18
  • IOT $23.32
  • P/E Ratio
  • TEVA N/A
  • IOT N/A
  • Revenue Growth
  • TEVA 4.40
  • IOT 39.11
  • 52 Week Low
  • TEVA $12.51
  • IOT $27.14
  • 52 Week High
  • TEVA $22.80
  • IOT $61.90
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 35.64
  • IOT 49.61
  • Support Level
  • TEVA $16.08
  • IOT $53.76
  • Resistance Level
  • TEVA $17.63
  • IOT $61.90
  • Average True Range (ATR)
  • TEVA 0.54
  • IOT 2.37
  • MACD
  • TEVA 0.01
  • IOT -0.15
  • Stochastic Oscillator
  • TEVA 39.82
  • IOT 28.61

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations: The solution connects physical operations data to the Connected Operations Cloud, which consists of the Data Platform and Application. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: